Literature DB >> 16157585

Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis.

Thomas Jank1, Dirk J Reinert, Torsten Giesemann, Georg E Schulz, Klaus Aktories.   

Abstract

The large cytotoxins of Clostridia species glycosylate and thereby inactivate small GTPases of the Rho family. Clostridium difficile toxins A and B and Clostridium sordellii lethal toxin use UDP-glucose as the donor for glucosylation of Rho/Ras GTPases. In contrast, alpha-toxin from Clostridium novyi N-acetylglucosaminylates Rho GTPases by using UDP-N-acetylglucosamine as a donor substrate. Based on the crystal structure of C. difficile toxin B, we studied the sugar donor specificity of the toxins by site-directed mutagenesis. The changing of Ile-383 and Gln-385 in toxin B to serine and alanine, respectively, largely increased the acceptance of UDP-N-acetylglucosamine as a sugar donor for modification of RhoA. The K(m) value was reduced from 960 to 26 mum for the double mutant. Accordingly, the potential of the double mutant of toxin B to hydrolyze UDP-N-acetylglucosamine was higher than that for UDP-glucose. The changing of Ile-383 and Gln-385 in the lethal toxin of C. sordellii allowed modification of Ras in the presence of UDP-N-acetyl-glucosamine and reduced the acceptance of UDP-glucose as a donor for glycosylation. Vice versa, the changing of the equivalent residues in C. novyi alpha-toxin from Ser-385 and Ala-387 to isoleucine and glutamine, respectively, reversed the donor specificity of the toxin from UDP-N-acetylglucosamine to UDP-glucose. These data demonstrate that two amino acid residues are crucial for the co-substrate specificity of clostridial glycosylating toxins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157585     DOI: 10.1074/jbc.M506836200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells.

Authors:  Gregor Guttenberg; Sven Hornei; Thomas Jank; Carsten Schwan; Wei Lü; Oliver Einsle; Panagiotis Papatheodorou; Klaus Aktories
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.

Authors:  Masahiro Nagahama; Akiko Ohkubo; Masataka Oda; Keiko Kobayashi; Katsuhiko Amimoto; Kazuaki Miyamoto; Jun Sakurai
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 3.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 4.  Clostridium difficile toxins: mediators of inflammation.

Authors:  Aimee Shen
Journal:  J Innate Immun       Date:  2012-01-10       Impact factor: 7.349

5.  The molecular pathogenesis of Clostridium difficile-associated disease.

Authors:  David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 6.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

7.  Conformational analysis of Clostridium difficile toxin B and its implications for substrate recognition.

Authors:  Rebecca Swett; G Andrés Cisneros; Andrew L Feig
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 8.  Large Clostridial Toxins: Mechanisms and Roles in Disease.

Authors:  Kathleen E Orrell; Roman A Melnyk
Journal:  Microbiol Mol Biol Rev       Date:  2021-06-02       Impact factor: 13.044

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.